Semaglutide is a synthetic version of glucagon-like peptide-1 (GLP-1) and thus mimics the action of this human incretin. Unlike other GLP-1 agonists, semaglutide resists degradation linked to the dipeptidyl peptidase-IV enzyme. Thanks to a mechanism that stimulates insulin and reduces glucagon secretions in a glucose-dependent manner, semaglutide has been shown to reduce fasting and postprandial blood glucose levels.

NetPeps offers products solely for research and development purposes, not for human consumption, medical, or therapeutic applications. Our products should not be misconstrued or substituted as prescription drugs. We do not dispense any prescription medications and are not a pharmacy. The US Food and Drug Administration has not assessed the assertions made on our website. Products are not intended to diagnose, treat, cure, or prevent any medical conditions or diseases.